1-11 of 11
cell therapy
Close
Sort by
Journal Articles

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Clinical Trials & Observations
Lori Muffly, Vandana Sundaram, Connie Chen, Ilana Yurkiewicz, Eric Kuo, Sarah Burnash, Jay Y. Spiegel, Sally Arai, Matthew J. Frank, Laura J. Johnston, Robert Lowsky, Everett H. Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Parveen Shiraz, Judith A. Shizuru, Wen-Kai Weng, Michaela Liedtke, Hyma T. Vempaty, David B. Miklos
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3147–3151.
https://doi.org/10.1182/bloodadvances.2021004234
Published: 2021
Includes: Supplemental data
Journal Articles

Immunotherapy perspectives in the new era of B-cell editing

Natsuko Ueda, Marine Cahen, Yannic Danger, Jérôme Moreaux, Christophe Sirac, Michel Cogné
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1770–1779.
https://doi.org/10.1182/bloodadvances.2020003792
Published: 2021
Journal Articles

The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome

Iosifina P. Foskolou, Laura Barbieri, Aude Vernet, David Bargiela, Pedro P. Cunha, Pedro Velica, Eunyeong Suh, Sandra Pietsch, Rugile Matuleviciute, Helene Rundqvist, Dominick McIntyre, Ken G. C. Smith, Randall S. Johnson
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4483–4493.
https://doi.org/10.1182/bloodadvances.2020002309
Published: 2020
Includes: Supplemental data
Journal Articles

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

Clinical Trials & Observations
Stephen J. Schuster, Richard T. Maziarz, Elisha S. Rusch, Junlong Li, James E. Signorovitch, Vadim V. Romanov, Frederick L. Locke, David G. Maloney
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1432–1439.
https://doi.org/10.1182/bloodadvances.2019001304
Published: 2020
Includes: Supplemental data
Journal Articles

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

Clinical Trials & Observations
Richard T. Maziarz, Stephen J. Schuster, Vadim V. Romanov, Elisha S. Rusch, Junlong Li, James E. Signorovitch, David G. Maloney, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1440–1447.
https://doi.org/10.1182/bloodadvances.2019001305
Published: 2020
Includes: Supplemental data
Journal Articles

Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults

Clinical Trials & Observations
Benjamin A. Derman, Keriann Kordas, Jean Ridgeway, Selina Chow, William Dale, Sang Mee Lee, Elingel Aguada, Andrzej J. Jakubowiak, Jagoda Jasielec, Justin Kline, Satyajit Kosuri, Richard A. Larson, Hongtao Liu, Mylove Mortel, Olatoyosi Odenike, Jennifer Pisano, Peter Riedell, Wendy Stock, Michael R. Bishop, Andrew S. Artz
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3488–3498.
https://doi.org/10.1182/bloodadvances.2019000790
Published: 2019
Includes: Supplemental data
Journal Articles

Large-scale in vitro production of red blood cells from human peripheral blood mononuclear cells

Steven Heshusius, Esther Heideveld, Patrick Burger, Marijke Thiel-Valkhof, Erica Sellink, Eszter Varga, Elina Ovchynnikova, Anna Visser, Joost H. A. Martens, Marieke von Lindern, Emile van den Akker
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3337–3350.
https://doi.org/10.1182/bloodadvances.2019000689
Published: 2019
Includes: Supplemental data
Journal Articles

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Clinical Trials & Observations
Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M. Vercellotti, Todd E. DeFor, Julie M. Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1970–1980.
https://doi.org/10.1182/bloodadvances.2018028332
Published: 2019
Includes: Supplemental data
Journal Articles

Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient

Clinical Trials & Observations
Jian-Ping Zhang, Rui Zhang, Shih-Ting Tsao, Yu-Chen Liu, Xiaochuan Chen, Dao-Pei Lu, Paul Castillo, Lung-Ji Chang
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1691–1695.
https://doi.org/10.1182/bloodadvances.2018017004
Published: 2018
Journal Articles

Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide

Clinical Trials & Observations
Franco Aversa, Esther Bachar-Lustig, Noga Or-Geva, Lucia Prezioso, Sabrina Bonomini, Ilenia Manfra, Alessandro Monti, Chiara Schifano, Yael Zlotnikov-Klionsky, Massimo F. Martelli, Gabriella Sammarelli, Maria Sassi, Maurizio Soli, Silvia Giuliodori, Magda Benecchi, Nicola Giuliani, Frank Lohr, Silvia Pratissoli, Yair Reisner
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2166–2175.
https://doi.org/10.1182/bloodadvances.2017009423
Published: 2017
Includes: Supplemental data
Journal Articles

Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge

Michaela Kuhlen, Marina Kunstreich, Kathinka Krull, Roland Meisel, Arndt Borkhardt
Journal: Blood Advances
Blood Adv (2017) 1 (14): 981–994.
https://doi.org/10.1182/bloodadvances.2017007286
Published: 2017